Molecular Integrated Risk Group Stratification & Testing for Molecular and Conventional Parameters: When, What, Why, and How?
ESGO eAcademy, Faculty / Presenters,
4151553
Patient-Reported Outcomes With Pembrolizumab Plus Chemoradiotherapy For High-Risk, Locally Advanced Cervical Cancer: Interim Analysis 2 Results From The Randomised, Double-Blind, Phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study
ESGO eAcademy, Vladyslav Sukhin,
4151871
A Single-Arm, Multicenter, Phase II Study On Carboplatin-Paclitaxel-Pembrolizumab In Neoadjuvant Treatment Of Locally Advanced Cervical Cancer: The MITO CERV3 Study
ESGO eAcademy, Domenica Lorusso,
4151870
Efficacy And Safety Of Intravenous Administration Of High-Dose Selenium For Preventing Chemotherapy-Induced Peripheral Neuropathy In Platinum-Sensitive Recurrent Ovarian, Fallopian Or Primary Peritoneal Cancer: Study Protocol For A Phase III, Double-Blind, Randomized Study
ESGO eAcademy, Ga Won Yim,
4151794